Premenstrual Syndrome Treatment Market: Size, Share, Growth, Trends, and Forecast 2021-2026
According to the latest report by IMARC Group, titled “Premenstrual Syndrome Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the market to grow at a CAGR of XX% during 2021-2026.
Premenstrual syndrome (PMS)
refers to a set of emotional, physical, and psychological symptoms that occur
in women during the end of the luteal phase. It is caused by the elevated
levels of progesterone and estrogen. Some of the common PMS symptoms include
mood swings, breast tenderness, bloating, fatigue, anxiety, and body pain. PMS
treatment involves various medications that help to increase the levels of
serotonin hormone in the body. These treatments include analgesics,
antidepressants, nonsteroidal anti-inflammatory drugs (NSAIDs), ovarian
suppression agents, and hormonal contraceptives.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Premenstrual Syndrome Treatment Market Trends:
The increasing prevalence
of PMS and premenstrual dysphoric disorder (PMDD) is primarily driving the
market growth. The rising awareness regarding the availability of alternative
PMS treatment methods is further catalyzing the market growth. In line with
this, pharmaceutical companies are investing in research and development
(R&D) activities to launch medications with minimal side-effects, which is
contributing to the market growth. Additionally, the widespread adoption of
plant-based nutritional supplements for PMS relief is presenting numerous
growth opportunities to leading players in the market, thus creating a positive
outlook for the market.
Request Free Sample Report: https://www.imarcgroup.com/premenstrual-syndrome-treatment-market/requestsample
Premenstrual Syndrome Treatment Market 2021-2026 Analysis and
Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report
with the detailed profiles of the key players operating in the market.
AbbVie Inc., BASF SE, Bayer AG, Dr. Reddy’s Laboratories Ltd, Eli Lilly
and Company., GlaxoSmithKline Plc., H. Lundbeck A/S, Pfizer Inc. and SHIONOGI
& Co. Ltd.
The report has segmented the market on the basis on region, disc type,
material type and end user.
Breakup by Drug Type:
- Analgesics
- Antidepressants
- Oral
Contraceptives and Ovarian Suppression Agents
- Others
Breakup by Type:
- Prescription
- Prescription
Breakup by Distribution Channel:
- Hospital
Pharmacies
- Drug
Stores and Retail Pharmacies
- Online
Stores
Breakup by Region:
·
North
America
o
States
o
Canada
·
Asia-Pacific
o
China
o
Japan
o
India
o
South
Korea
o
Australia
o
Indonesia
United
o
Others
·
Europe
o
Germany
o
France
o
United
Kingdom
o
Italy
o
Spain
o
Russia
o
Others
·
Latin
America
o
Brazil
o
Mexico
o
Others
·
Middle
East and Africa
Ask Analyst for Customization and Explore Full Report with TOC &
List of Figure: https://www.imarcgroup.com/premenstrual-syndrome-treatment-market
Key highlights of the report:
- Market
Performance (2015-2020)
- Market
Outlook (2021-2026)
- Porter’s
Five Forces Analysis
- Market
Drivers and Success Factors
- SWOT
Analysis
- Value
Chain
- Comprehensive
Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope
of the report, we can provide it to you as a part of the customization.
If you want latest primary and secondary data (2021-2026) with Cost Module,
Business Strategy, Distribution Channel, etc. Click request free sample report,
published report will be delivered to you in PDF format via email within 24 to
48 hours of receiving full payment.
About Us
IMARC Group is a leading market research company that offers management
strategy and market research worldwide. We partner with clients in all sectors
and regions to identify their highest-value opportunities, address their most
critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic
and technological developments for business leaders in pharmaceutical,
industrial, and high technology organizations. Market forecasts and industry
analysis for biotechnology, advanced materials, pharmaceuticals, food and
beverage, travel and tourism, nanotechnology and novel processing methods are
at the top of the company’s expertise.
Contact Us:
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Comments
Post a Comment